Atlas Trials

Phase I, Open-Label, Dose-Escalation Study of AZD4877 in Solid Tumors

Clinical trial NCT00389389 · COMPLETED

Trial details

NCT number
NCT00389389
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Neoplasms
Start date
2006-09-01
Primary completion
2008-08-01
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.